Fierce Pharma Mix Logo.png Fierce Pharma Mix Logo.png
Webinar

From Discovery to Commercial Supply: Managing Peptide Manufacturing Risks

ET
60 Minutes

How can you deliver peptide material on time, maintain quality, and prepare for growing demand?

Join PharmaBlock OPC (Oligo, Peptide, Conjugate) team to explore manufacturing strategies that connect early peptide design with IND-enabling studies, clinical development, and commercial supply. Learn where SPPS, LPPS, continuous-flow (CF-LPPS), and enzyme-assisted synthesis (EAPS) can fit as your program advances.

What you’ll learn:

  • Identify manufacturing risks early through peptide design and building-block selection.
  • Balance delivery timelines with route selection, impurity control, and purification.
  • Manage process changes and scale-up to support reliable, cost-effective supply.

Who should attend: Scientists and leaders in peptide discovery, process development, analytical, CMC, quality, regulatory, manufacturing, and outsourcing.

Register now to help keep your peptide program moving forward.

Speakers

0

Dr. Chen Liu

Ph.D. graduate from China Pharmaceutical University. Author of 9 peer-reviewed publications and inventor on 17 patent applications and granted patents. With 7 years of industry experience, including experience across 50+ peptide and peptide conjugate projects and 10+ API process development programs, he has expertise in peptide chemistry, process development, manufacturing, and CMC strategy. He has contributed to the advancement of multiple peptide programs into the clinical development stage and possesses extensive hands-on experience in the development of peptides and peptide conjugates.

Register here!

Date/Time:
ET